UBS OCONNOR LLC - PHOENIX BIOTECH ACQUISITION ownership

PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K105. A total of 11 filers reported holding PHOENIX BIOTECH ACQUISITION in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS OCONNOR LLC ownership history of PHOENIX BIOTECH ACQUISITION
ValueSharesWeighting
Q3 2022$1,928,000,000
-8.5%
190,898
-9.1%
0.04%
+19.4%
Q2 2022$2,106,000,000
+3.0%
210,009
+1.8%
0.03%
+55.0%
Q4 2021$2,045,000,000206,3080.02%
Other shareholders
PHOENIX BIOTECH ACQUISITION shareholders Q3 2023
NameSharesValueWeighting ↓
Beryl Capital Management LLC 542,376$5,570,3642.24%
DIFESA CAPITAL MANAGEMENT, LP 125,000$1,287,5001.00%
Lynwood Capital Management Inc. 59,615$6130.74%
Sage Rock Capital Management LP 183,998$1,889,7150.59%
HGC Investment Management Inc. 1,000,000$10,1800.44%
GRITSTONE ASSET MANAGEMENT LLC 34,026$349,4570.44%
MMCAP International Inc. SPC 370,000$3,796,2000.38%
METEORA CAPITAL, LLC 168,532$1,730,8740.37%
Exos TFP Holdings LLC 125,771$1,290,4100.36%
Bulldog Investors, LLP 90,650$931,4290.28%
View complete list of PHOENIX BIOTECH ACQUISITION shareholders